Yu-Hsin Wan

Cancer Research Center

Papers

1

Total Citations

8

H-Index

1

About

Yu-Hsin Wan is a prominent virologist whose research focuses on antibody-mediated immunity against emerging coronaviruses. Her most significant contribution lies in the isolation and characterization of cross-neutralizing antibodies from COVID-19 convalescent subjects, a study that has garnered 8 citations and provided critical insights into pan-coronavirus vaccine design. By identifying antibodies capable of neutralizing multiple coronavirus strains, Wan's work addresses a key challenge in pandemic preparedness—developing broad-spectrum therapeutics that remain effective as viruses mutate. Her research bridges fundamental immunology and translational medicine, offering a blueprint for combating future coronavirus outbreaks. Wan’s findings have implications for both therapeutic antibody cocktails and universal vaccine strategies, highlighting her role in advancing our understanding of viral cross-reactivity. Her meticulous approach to antibody discovery and characterization has established her as a rising authority in infectious disease research, with her work frequently cited in studies on COVID-19 immunity and next-generation antiviral strategies.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects
8 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 28
🏛 Institutions: Cancer Research Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago